Cargando…
Large-scale integration of cancer microarray data identifies a robust common cancer signature
BACKGROUND: There is a continuing need to develop molecular diagnostic tools which complement histopathologic examination to increase the accuracy of cancer diagnosis. DNA microarrays provide a means for measuring gene expression signatures which can then be used as components of genomic-based diagn...
Autores principales: | Xu, Lei, Geman, Donald, Winslow, Raimond L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950528/ https://www.ncbi.nlm.nih.gov/pubmed/17663766 http://dx.doi.org/10.1186/1471-2105-8-275 |
Ejemplares similares
-
Merging microarray data from separate breast cancer studies provides a robust prognostic test
por: Xu, Lei, et al.
Publicado: (2008) -
Identifying Personalized Metabolic Signatures in Breast Cancer
por: Baloni, Priyanka, et al.
Publicado: (2020) -
Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions
por: Lord, Christopher J, et al.
Publicado: (2020) -
Identifying Robust Microbiota Signatures and Interpretable Rules to Distinguish Cancer Subtypes
por: Chen, Lei, et al.
Publicado: (2020) -
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
por: Starmans, M H W, et al.
Publicado: (2008)